Oyedeji Oluwafemifola, Maples Jill M, Gregory Samantha, Chamberlin Shauntá M, Gatwood Justin D, Wilson Alexandria Q, Zite Nikki B, Kilgore Larry C
Department of Public Health, The University of Tennessee, Knoxville, TN 37996, USA.
Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tennessee, Knoxville, TN 37920, USA.
Vaccines (Basel). 2021 Nov 19;9(11):1360. doi: 10.3390/vaccines9111360.
About 45:000 cancers are linked to HPV each year in the United States alone. The HPV vaccine prevents cancer and is highly effective, yet vaccination coverage remains low. Pharmacies can play a meaningful role in increasing HPV vaccination access due to their availability and convenience. However, little is known about pharmacists' perceived barriers to HPV vaccination. The objective of this systematic review was to summarize existing literature on perceived barriers to administering HPV vaccination reported by pharmacists. Barriers identified from selected studies were synthesized and further grouped into patient, parental, (pharmacist's) personal, and system/organization barrier groups. Six studies were included in this review. The cost of the HPV vaccine, insurance coverage and reimbursement were commonly reported perceived barriers. Adolescent HPV vaccination barriers related to parental concerns, beliefs, and inadequate knowledge about the HPV vaccine. Perceived (pharmacist's) personal barriers were related to lack of information and knowledge about HPV vaccine and recommendations. At the system/organization level, barriers reported included lack of time/staff/space; difficulty in series completion; tracking and recall of patient; perceived competition with providers; and other responsibilities/vaccines taking precedence. Future strategies involving pharmacy settings in HPV-related cancer prevention efforts should consider research on multilevel pharmacy-driven interventions addressing barriers.
仅在美国，每年就有大约4.5万例癌症与HPV有关。HPV疫苗可预防癌症且效果显著，但疫苗接种率仍然很低。由于药店的可及性和便利性，它们在增加HPV疫苗接种机会方面可以发挥重要作用。然而，对于药剂师在HPV疫苗接种方面所感知到的障碍却知之甚少。本系统评价的目的是总结药剂师报告的关于HPV疫苗接种感知障碍的现有文献。从所选研究中确定的障碍进行了综合，并进一步分为患者、家长、（药剂师的）个人以及系统/组织障碍组。本评价纳入了六项研究。HPV疫苗的成本、保险覆盖范围和报销是常见的报告感知障碍。青少年HPV疫苗接种障碍与家长的担忧、观念以及对HPV疫苗的了解不足有关。（药剂师的）个人感知障碍与缺乏关于HPV疫苗及建议的信息和知识有关。在系统/组织层面，报告的障碍包括时间/人员/空间不足；完成接种系列有困难；患者追踪和召回；感知到与医疗服务提供者的竞争；以及其他职责/疫苗优先级更高。未来在HPV相关癌症预防工作中涉及药店环境的策略应考虑开展关于解决障碍的多层次药店驱动干预措施的研究。
